A 10% reduction in body weight lessens the chance that non-alcoholic fatty liver disease will progress to non-alcoholic steatohepatitis or to early fibrosis, according to a review in Diabetes, Obesity and Metabolism. Fatty liver disease has become a rapidly growing public health problem, and good communication and shared decision-making are key to helping patients lower weight and protect the liver, says Jay Shubrook, professor and metabolic specialist at Touro University California College of Osteopathic Medicine and co author of the review.
Full Story: Medscape (free registration) (6/20)